Table 2.
Effect of Characteristics on 30-Day Survival in the Low-acuity Cohort (n = 77)
| Characteristic | Survived ( n = 43), n (%) | Deceased n = 34, n (%) |
Bivariate OR (95% CI) | Bivariate P Value |
Multivariable OR (95% CI) | Multivariable P Value |
|---|---|---|---|---|---|---|
| Immunosuppressed | 32 (74.4) | 32 (94.1) | 0.18 (0.04–0.89) |
.022 | 0.24 (0.05–1.21) | .084 |
| Bacteremia source | ||||||
| Gastrointestinal | 11 (25.6) | 6 (17.6) | 1.60 (0.53–4.90) | .405 | … | … |
| Urinary tracta | 4 (9.3) | 1 (2.9) | 3.38 (0.36–31.79) | .376 | … | … |
| Catheter-related | 16 (37.2) | 20 (58.8) | 0.42 (0.17–1.04) | .059 | 0.51 (0.19–1.38) | .185 |
| Other or unknown | 12 (27.9) | 7 (20.6) | 1.49 (0.51–4.33) | .459 | … | … |
| fAUC/MIC >27.43 | 31 (72.1) | 14 (41.2) | 3.69 (1.42–9.58) | .006 | 3.10 (1.14–8.38) | .026 |
Abbreviations: CI, confidence interval; fAUC/MIC, area under the free drug concentration-time curve to minimum inhibitory concentration ratio; OR, odds ratio
aBivariate statistical analysis performed with Fisher’s exact test.